Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19

A Kroemer, K Khan, M Plassmeyer… - Journal of …, 2020 - journal-of-hepatology.eu
[2] Baala L, Hadj-Rabia S, Hamel-Teillac D, Hadchouel M, Prost C, Leal SM, et al.
Homozygosity mapping of a locus for a novel syndromic ichthyosis to chromosome 3q27 …

[HTML][HTML] Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination

SK Lee, JH Kwon, N Yoon, SH Lee… - Journal of Hepatology, 2022 - ncbi.nlm.nih.gov
Fig. 1. Histopathological findings and clinical course of the patient.(A) On H&E staining,
moderate-to-severe portal inflammation, piecemeal necrosis, interface hepatitis (left upper …

[HTML][HTML] Management of patients with autoimmune liver disease during COVID-19 pandemic

A Lleo, P Invernizzi, AW Lohse, A Aghemo… - Journal of …, 2020 - ncbi.nlm.nih.gov
The underlying mechanism is unknown but might be related to impaired innate immunity to
the virus. In particular, there are abundant ACE2 receptors in the small intestine and …

Immune boosting gone wrong? A COVID-concoction-conundrum

H Gupta, N Nigam, S Singh, A Roy… - Journal of clinical and …, 2022 - ncbi.nlm.nih.gov
We read with interest the case series by Nagral A et al. 1 The authors highlight a vexing
predicament brought to the fore amidst the frequent usage of “immune boosters” during the …

An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: Coincidence, autoimmunity or drug-related liver injury

F Lodato, A Larocca, A D'Errico… - Journal of …, 2021 - journal-of-hepatology.eu
We read with interest the article “Autoimmune hepatitis developing after coronavirus disease
2019 (COVID-19) vaccine: Causality or casualty?” by Bril et al. recently published in Journal …

SARS-CoV-2 related liver impairment–perception may not be the reality

CA Philips, R Ahamed… - Journal of hepatology, 2020 - journal-of-hepatology.eu
[1] Qi X, Liu C, Jiang Z, Gu Y, Zhang G, Shao C, et al. Multicenter analysis of clinical
characteristics and outcome of COVID-19 patients with liver injury. J Hepatol 2020; 73 (2) …

SARS-CoV-2: Is the liver merely a bystander to severe disease?

MN Bangash, JM Patel, D Parekh… - Journal of …, 2020 - journal-of-hepatology.eu
We read the recent article from Wang et al. with great interest. 1 They report that severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients with>− 1-week …

[PDF][PDF] COVID-19 and liver disease

J Sun, A Aghemo, A Forner, L Valenti - Liver international, 2020 - air.unimi.it
Since December 2019, patients with unexplained pneumonia have been found in Wuhan,
Hubei Province, China, which was caused by a novel coronavirus that had not been …

Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury

X Qi, C Liu, Z Jiang, Y Gu, G Zhang… - Journal of …, 2020 - journal-of-hepatology.eu
We read with interest the paper “Epidemiological and clinical characteristics of 99 cases of
2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”, in which 43 …

[HTML][HTML] Increased hepatic expression of SARS-CoV-2 entry points and proinflammatory cytokines in cirrhosis

N Limon-De La Rosa, E Cervantes-Alvarez… - Clinical …, 2022 - ncbi.nlm.nih.gov
It has been recently reported that patients with cirrhosis have significantly higher mortality
following severe acute respiratory syndrome coronavrisu 2 (SARS-CoV-2) infection …